B Cell News and Research

RSS
Exploring simultaneous and sequential COVID-19 vaccine candidate

Exploring simultaneous and sequential COVID-19 vaccine candidate

10 May 2022
Simulating molecular dynamics of SARS-CoV-2 spike variants in the locked conformation

Simulating molecular dynamics of SARS-CoV-2 spike variants in the locked conformation

10 May 2022
Investigating the role of cyclins and cyclin-dependent kinases in host restriction of SARS-CoV-2 infection

Investigating the role of cyclins and cyclin-dependent kinases in host restriction of SARS-CoV-2 infection

10 May 2022
Detecting treatments for autoimmune disease using an immune ‘fingerprint’

Detecting treatments for autoimmune disease using an immune ‘fingerprint’

10 May 2022
Sphere Fluidics strengthens commercial team with three new senior hires

Sphere Fluidics strengthens commercial team with three new senior hires

From Fluidic Sciences and Sphere Bio 10 May 2022
bit.bio launches Huntington’s disease human cell model

bit.bio launches Huntington’s disease human cell model

From bit.bio 10 May 2022
A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

10 May 2022
Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

10 May 2022
The potential for SARS-CoV-2 to be transmitted biologically or mechanically by arthropods

The potential for SARS-CoV-2 to be transmitted biologically or mechanically by arthropods

10 May 2022
mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

mRNA boosters enhance neutralization of SARS-CoV-2 BA.1, BA.2 and BA.3

10 May 2022
Severe symptoms result in high titers of SARS-CoV-2 antibodies

Severe symptoms result in high titers of SARS-CoV-2 antibodies

9 May 2022
Gene therapy effectively reduces neuropathic pain in mice with spinal cord injuries

Gene therapy effectively reduces neuropathic pain in mice with spinal cord injuries

9 May 2022
LJI researchers uncover new drug target for severe asthma, lung fibrosis

LJI researchers uncover new drug target for severe asthma, lung fibrosis

9 May 2022
Novel drug target may help overcome resistance to EZH2 inhibitors in SMARCB1 mutated cancers

Novel drug target may help overcome resistance to EZH2 inhibitors in SMARCB1 mutated cancers

9 May 2022
T cell behavior informs metastatic melanoma outcomes

T cell behavior informs metastatic melanoma outcomes

9 May 2022
Study identifies interleukin-6 as a potential target in refining cancer therapies

Study identifies interleukin-6 as a potential target in refining cancer therapies

9 May 2022
Mathematical modeling reveals important factors that govern the effectiveness of adaptive therapy

Mathematical modeling reveals important factors that govern the effectiveness of adaptive therapy

9 May 2022
Targeting interleukin-6 could help reduce immune-related adverse events from immunotherapy

Targeting interleukin-6 could help reduce immune-related adverse events from immunotherapy

9 May 2022
Third BNT162b2 dose elicits more durable immune response than second dose

Third BNT162b2 dose elicits more durable immune response than second dose

9 May 2022
Deoxyribonucleic acid nanostructure sensor found to rapidly detect and inhibit SARS-CoV-2

Deoxyribonucleic acid nanostructure sensor found to rapidly detect and inhibit SARS-CoV-2

9 May 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback